Iron through a vein for anemia in women around childbirth
Looks at intravenous iron for anemic women before and after giving birth.
Key facts
- Who runs it
- Johann Wolfgang Goethe University Hospital
- Where
- Germany2 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Impact of Iron Supplementation During Pregnancy
- Status
- Not yet recruiting
- People taking part
- 800 people, planned
- Started
- 1 Oct 2026
- Expected to end
- 31 Dec 2028
- Type of study
- Observational
- Treatments tested
- Iron
- Record updated
- 11 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women. It studies whether iron given through a vein improves blood levels and quality of life before and after giving birth.
- Age
- 18 Years and older
- Sex
- Female
- Earlier treatment
- People who had iron given through a vein within 3 months before enrolment cannot join.
Main reasons for not taking part
- Thalassemia or sickle cell disease
- Aplastic anemia or hemochromatosis
- Long-term inflammatory diseases linked to anemia of chronic disease
- Severe kidney failure (severe renal insufficiency)
- Iron given through a vein within 3 months before enrolment
This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnancy
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Pregnancy
Who cannot take part
- Intravenous iron administration within 3 months prior to enrollment
- Sickle cell disease
- Chronic inflammatory diseases associated with anemia of chronic disease
- Severe renal insufficiency
- Thalassemia
- Aplastic anemia
- Hemochromatosis
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
During pregnancy, iron deficiency is the most common cause of anemia. Anemia is very common during pregnancy and after childbirth. Around half of pregnant women develop anemia, and after delivery, up to 85% of women may be affected.
Read full original descriptionShow less
This study looks at whether iron given through a vein (intravenous iron) can improve blood levels and how women feel and function in everyday life before and after giving birth.
Treatments tested
- Iron
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Iron Supplementation on Haemoglobin Levels and Quality-of-life in Iron-deficient (Anaemic) Women Before and After Delivery
- Plain-language title
- Iron through a vein for anemia in women around childbirthGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 11 September 2026